CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

Kangkook Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Cancer Research and Treatment. 2020;52(1):292-300. Published online 2019 July 26 DOI: https://doi.org/10.4143/crt.2019.186

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

Kangkook Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Cancer Research and Treatment. 2020;52(1):292-300

Link1

Link2 Link3

Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens

Sarah Waliany, Heather Wakelee, Kavitha Ramchandran, Millie Das, Jane Huang, Nathaniel Myall, Connie Li, Judy Pagtama, Alison Holmes Tisch, Joel W. Neal

Clinical Lung Cancer. 2022;23(6):498-509

Link1 Link2

Patients With Advanced Non–Small Cell Lung Cancer Requiring Inpatient Medical Oncology Consultation: Characteristics, Referral Patterns, and Outcomes

Joanna Gotfrit, Tinghua Zhang, Silvia Zanon-Heacock, Paul Wheatley-Price

Clinical Lung Cancer. 2016;17(4):292-300

Link1 Link2

A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non–Small-Cell Lung Cancer

Ramaswamy Govindan

Clinical Lung Cancer. 2010;11(1):8-12

Link1 Link2

Treatment Outcome and Clinical Characteristics of HER2 Mutated Advanced Non-Small Cell Lung Cancer Patients in China

Fei Xu, Guangjian Yang, Haiyan Xu, Lu Yang, Weini Qiu, Junling Li, Yan Wang

. 2019;

Link1 Link2

Screening for HER2 alterations and HER2-targeted therapy in non-small cell lung cancer

Ichiro Kinoshita

Annals of Oncology. 2015;26:vii40

Link1 Link2 Link3

P50.09 Characteristics and Clinical Outcomes of HER2 Mutated Non-small Cell Lung Cancer Patients Detected by NGS in Routine Clinical Practice

Y. Han, S.M. Lim, H.R. Kim, M.H. Hong, B.C. Cho, B. Ahn

Journal of Thoracic Oncology. 2021;16(10):S1117-S1118

Link1 Link2

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small-Cell Lung Cancer

Tejas Patil, Rao Mushtaq, Sydney Marsh, Christine Azelby, Miheer Pujara, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Erin L. Schenk, Jose M. Pacheco, Paul A. Bunn, D. Ross Camidge, Robert C. Doebele

Clinical Lung Cancer. 2020;21(3):e191-e204

Link1 Link2

Clinical characteristics of patients with stage III non-small cell lung cancer (NSCLC) receiving combination chemotherapy

Lung Cancer. 1986;2(1-2):63

Link1 Link2

Comment on the data of the article titled “Second Primary Non–Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients”

Junmiao Wen

Clinical Lung Cancer. 2019;20(6):e619

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.